Advanced-stage CD30-positive mycosis fungoides: Clinical experience with brentuximab vedotin

被引：0
|
作者：
Vico-Alonso, Cristina [1 ]
Jose Andres-Lencina, Juan [1 ]
Aragon-Miguel, Raquel [1 ]
Calleja-Algarra, Alba [1 ]
Pinilla-Martin, Belen [1 ]
Sanchez-Velazquez, Alba [1 ]
Munoz-Gonzalez, Hector [1 ]
Penalba, Maria [1 ]
Velasco Tamariz, Virginia [1 ]
Postigo LLorente, Concepcion [2 ]
Ortiz-Romero, Pablo L.
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
16223
引用
收藏
页码：AB173 / AB173
页数：1
相关论文
共 50 条
  • [31] Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas
    Wagner, Sandro M.
    Melchardt, Thomas
    Egle, Alexander
    Magnes, Teresa
    Skrabs, Cathrin
    Staber, Philipp
    Simonitsch-Klupp, Ingrid
    Panny, Michael
    Lehner, Barbara
    Greil, Richard
    Keil, Felix
    Jager, Ulrich
    Sillaber, Christian
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (03) : 251 - 258
  • [32] Treatment of CD30-negative tumor-stage mycosis fungoides with brentuximab
    Goyal, Amrita
    Lazaryan, Aleksandr
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB288 - AB288
  • [33] Sezary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis
    Behle, Valeria
    Von Braunmuehl, Tanja
    Sayehli, Cyrus
    Gesierich, Anja
    Goebeler, Matthias
    Geissinger, Eva
    Wobser, Marion
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 973 - 975
  • [34] Brentuximab Vedotin-Based Treatment in Patients with CD30-Positive Lymphoma: A Retrospective Analysis
    Li, Yixue
    Zeng, Ruolan
    Xia, Chen
    Li, Yajun
    He, Yizi
    Wang, Caiqin
    Zhou, Hui
    BLOOD, 2024, 144 : 6465 - 6465
  • [35] Retreatment with brentuximab vedotin in CD30-positive hematologic malignancies: A phase II study.
    Bartlett, Nancy
    Brice, Pauline
    Chen, Robert W.
    Fanale, Michelle A.
    Gopal, Ajay K.
    Matous, Jeffrey
    Rosenblatt, Joseph David
    Grove, Laurie E.
    Forero-Torres, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Activity of Brentuximab Vedotin (Adcetris TM) in Replaced Progressive CD30+Transformed Mycosis Fungoides (TMF)
    Devarakonda, Srinivas S.
    Haddad, Philip A.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 781 - 781
  • [37] PERSISTENCE OF CD30 EXPRESSION IN CD30-POSITIVE LYMPHOMAS FOLLOWING TREATMENT WITH BRENTUXIMAB VEDOTIN (SGN-35)
    Chen, W.
    Nathwani, N.
    Forman, S.
    Popplewell, L.
    Krishnan, A.
    Gomez, C.
    Karanes, C.
    Smith, E.
    Farol, L.
    Thomas, S.
    Kim, Y.
    HAEMATOLOGICA, 2012, 97 : 81 - 82
  • [38] Emerging Treatment Options for Advanced-Stage Mycosis Fungoides
    Drews, Reed E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (33) : 4064 - 4070
  • [39] Brentuximab as a Treatment for CD30+ Mycosis Fungoides and Sezary Syndrome
    Mehra, Tarun
    Ikenberg, Kristian
    Moos, Rudolf Maria
    Benz, Rudolf
    Nair, Gayathri
    Schanz, Urs
    Haralambieva, Eugenia
    Hoetzenecker, Wolfram
    Dummer, Reinhard
    French, Lars Einar
    Guenova, Emmanuella
    Cozzio, Antonio
    JAMA DERMATOLOGY, 2015, 151 (01) : 73 - 77
  • [40] Effective Response in therapy-resistant folliculotropic primary CD30-negative Mycosis fungoides with Brentuximab (Vedotin)
    Kolassa, M.
    Berkes, N.
    Dabrowski, E.
    Schneiderbauer, R.
    Cornelius, B.
    Dippel, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 42 - 42
12345